Tamiflu

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Influenza

Phase 1

A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection

CompletedNCT00988325

Hoffmann-La RocheInfluenza

Start: 2011-01-31End: 2012-04-30Updated: 2017-03-20

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

TerminatedNCT01053663

Hoffmann-La RocheInfluenza

Start: 2011-01-31End: 2013-01-31Updated: 2016-07-27

Related Papers

Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.

2015-07-013 citations

Safety, Virology and Pharmacokinetics of Oseltamivir in Infants with Laboratory-Confirmed Influenza: A Phase I/II, Prospective, Open-Label, Multicentre Clinical Trial

Antiviral Therapy2014-11-018 citations